Stay updated with breaking news from Agios Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- "Acute Myeloid Leukemia (AML) Treatment Market in APAC by Type and Geography - Forecast and Analysis 2022-2026" has been added to Technavio's...
/PRNewswire/ -- "Acute Myeloid Leukemia (AML) Treatment Market in APAC by Type and Geography - Forecast and Analysis 2022-2026" has been added to Technavio's...
/PRNewswire/ -- The sarcoma therapeutics market is poised to grow by USD 1.18 bn from 2021 to 2026, progressing at a CAGR of almost 9% during the forecast...
Mitapivat (Pyrukynd) is the first disease-modifying agent for hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Pediatric Low-Grade Glioma (pLGG) – Market outlook, Epidemiology, Market Forecast and Competitive Landscape Report – 2020 To 2030